Sørbye SW

ORCID: 0000-0002-8250-3992 · 1 paper in corpus
2020
Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries.
EClinicalMedicine ·doi:10.1016/j.eclinm.2020.100401

BackgroundThe quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy study (NCT00092534). We report long-term effectiveness and immunogenicit…